DENALI THERAPEUTICS INC's ticker is and the CUSIP is 24823R905. A total of 2 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26 | -50.9% | 1,300 | -27.8% | 0.00% | – |
| Q2 2023 | $53 | -60.7% | 1,800 | -69.5% | 0.00% | – |
| Q1 2023 | $135 | -58.5% | 5,900 | -49.6% | 0.00% | – |
| Q4 2022 | $325 | -99.9% | 11,700 | -5.6% | 0.00% | – |
| Q3 2022 | $380,000 | +92.9% | 12,400 | +85.1% | 0.00% | – |
| Q2 2022 | $197,000 | +515.6% | 6,700 | +570.0% | 0.00% | – |
| Q1 2022 | $32,000 | +146.2% | 1,000 | +233.3% | 0.00% | – |
| Q4 2021 | $13,000 | -58.1% | 300 | -25.0% | 0.00% | – |
| Q3 2021 | $31,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q2 2021 | $31,000 | -87.6% | 400 | +809.1% | 0.00% | – |
| Q1 2021 | $251,000 | – | 44 | -86.2% | 0.00% | – |
| Q4 2020 | $0 | – | 320 | +3100.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 10 | -76.7% | 0.00% | – |
| Q1 2020 | $75,000 | -86.5% | 43 | -86.6% | 0.00% | -100.0% |
| Q4 2019 | $557,000 | +2431.8% | 320 | +2033.3% | 0.00% | – |
| Q3 2019 | $22,000 | +175.0% | 15 | +275.0% | 0.00% | – |
| Q2 2019 | $8,000 | +100.0% | 4 | +100.0% | 0.00% | – |
| Q1 2019 | $4,000 | -42.9% | 2 | -60.0% | 0.00% | – |
| Q2 2018 | $7,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $2,063 | 0.00% |
| SIMPLEX TRADING, LLC | 1,300 | $26 | 0.00% |
| JANE STREET GROUP, LLC | 20,700 | $427,041 | 0.00% |